RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Pharming Group N.V. Stock and on which exchange is it traded?
The symbol for Pharming Group N.V. is PHGN.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Pharming Group N.V. Stock?
Pharming Group N.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Pharming Group N.V. Stock?
Pharming Group N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pharming Group N.V. Stock.

What's the current price of Pharming Group N.V. Stock?
As of the end of day on the 2023-12-22, the price of an Pharming Group N.V. (PHGN.F) share was 1.22€.

What is the 52-week high and low for Pharming Group N.V. Stock?
The 52-week high for Pharming Group N.V. Stock is 1.48€ and the 52-week low is 0.92€.
Click to get the best stock tips daily for free!

About Pharming Group N.V.

Pharming Group N.V. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment ... PHGN.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT